Siemens Healthineers AG (SMMNY)
| Market Cap | 57.76B |
| Revenue (ttm) | 24.94B |
| Net Income (ttm) | 2.17B |
| Shares Out | n/a |
| EPS (ttm) | 1.93 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.30 (1.10%) |
| Ex-Dividend Date | Apr 19, 2024 |
| Volume | 1,735 |
| Open | 25.88 |
| Previous Close | 25.74 |
| Day's Range | 25.57 - 25.94 |
| 52-Week Range | 25.54 - 31.73 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2024 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and... [Read more]
Financial Performance
In 2024, Siemens Healthineers AG's revenue was 22.36 billion, an increase of 3.15% compared to the previous year's 21.68 billion. Earnings were 1.94 billion, an increase of 28.69%.
Financial numbers in EUR Financial StatementsNews
Siemens Healthineers AG (SEMHF) Q4 2024 Earnings Call Transcript
Siemens Healthineers reports Q4 results
Siemens Healthineers meets full-year earnings forecast
German medical technology company Siemens Healthineers reported a full-year adjusted earnings before interest and taxes (EBIT) and revenue growth in line with analysts' consensus on Wednesday.
Siemens Healthineers: My Current Pick In Medtech Ahead Of Q4 2024
Patient Testing Set to be Overhauled with Automation from Siemens Healthineers that Tackles Lab Workflow and Staffing Challenges
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers now offers Atellica Integrated Automation on the Atellica CI Analyzer,1 to consolidate 25 tasks typically handled manually by clinical laboratory...
Siemens Healthineers to showcase their latest cross-disciplinary solutions
To overcome the worlds most threatening diseases at Global Health 2024
Siemens Healthineers cut to neutral by UBS, Chinese competition cited
Together with Siemens Healthineers, Varian Highlights Software and Imaging Innovations to Enable Personalized Patient Care at ASTRO 2024
PALO ALTO, Calif.--(BUSINESS WIRE)-- #ASTRO24--Together with Siemens Healthineers, Varian Highlights Software and Imaging Innovations to Enable Personalized Patient Care at ASTRO 2024.
Novartis' Cholesterol-Lowering Drug Shows Encouraging Outcome In Late-Stage Study
Wednesday, Novartis AG (NYSE: NVS) released topline results from twice-yearly Leqvio (inclisiran) in the Phase 3 V-MONO study, which met its primary endpoints. V-MONO is part of the 60,000-patient Vi...
Fertility-related stocks are becoming more attractive, Barclays says
CNBC's Silvia Amaro takes a look at why investors are growing more interested in fertility-related stocks.
Siemens Healthineers seeks €200M Novartis deal to boost cancer imaging business: FT
Siemens Healthineers (SEMHF) to acquire Novartis' (NVS) radioactive chemicals business for €200M, expanding its PET radiopharma presence. Read more here.
Siemens Healthineers to buy Novartis unit for over $223 million, FT reports
Siemens Healthineers will pay more than 200 million euros ($223.8 million) to acquire the diagnostic arm of Advanced Accelerator Applications, owned by Novartis , the Financial Times reported on Satur...
Siemens Healthineers sees return to growth in China in Q4, CFO says
Jochen Schmitz, CFO of Siemens Healthineers, discusses the German healthcare firm's latest round of earnings.
Siemens Healthineers AG (SEMHF) Q3 2024 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SEMHF) Q3 2024 Earnings Conference Call July 31, 2024 2:30 AM ET Company Participants Marc Koebernick - Head-Investor Relations Bernd Montag - Chief Executive Officer Jo...
Siemens Healthineers hit by China order delays in Q3, but sees 2025 turnaround
German medical technology company Siemens Healthineers said on Wednesday its sales were hit by continued order delays in China in the third quarter, sending its shares more than 6% lower.
Human-Centered Engineering in the Lab Can Close the Distance Between Providers and Care: Siemens Healthineers to Exhibit How at ADLM 2024
CHICAGO--(BUSINESS WIRE)--ADLM 2024 Clinical Lab Expo--Siemens Healthineers has pushed the boundaries of medical engineering to improve patient care for more than 125 years. At the ADLM 2024 Clinical ...
AI in Medical Diagnostics Market Insights and Forecast, 2024-2033 - Top Ten Competitors Account for 56.02% of the Total Revenue, Led by Siemens Healthineers, Followed Closely by Merative L.P.
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "AI in Medical Diagnostics Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.
Siemens Healthineers: The Upside Is Clear To Me Over The Long Term
Siemens Healthineers reported good revenue growth and margin expansion in Q2 2024, with strong performance in Imaging, Varian, and Advanced Therapies segments. Despite a recent decline in share price,...
Siemens Healthineers: Softer Orders A Risk, But The Story Remains Sound
Healthcare capex demand has supported healthy order growth at Siemens Healthineers, as the company leverages new innovative platforms in Imaging (MRI, CT) and radiation oncology (Varian). The Street w...
Siemens Healthineers (SHL) 2024 Product Pipeline Analysis and Ongoing Clinical Trails Insights
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Siemens Healthineers AG (SHL) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. This report ...
Siemens Healthineers AG (SEMHF) Q1 2024 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SEMHF) Q1 2024 Results Conference Call May 7, 2024 2:30 AM ET Company Participants Marc Koebernick - IR Bernhard Montag - CEO Jochen Schmitz - CFO Conference Call Partic...
Siemens Healthineers Q2 revenue slightly misses expectations, faces headwinds in China
German health technology company Siemens Healthineers reported on Tuesday second-quarter revenue growth slightly below consensus expectations, as it was hurt by declining revenue in China.
Enable Me Cites New Research by Siemens Healthineers Concluding Job-Related Physical Stresses and Strains for Radiologists Are Resulting in More Turnover and Fewer Entering the Profession
TAMPA, Fla.--(BUSINESS WIRE)--Enable Me, a VELA Medical company, today cited major new research by Siemens Healthineers entitled, “The future of Mammography: 4 critical challenges,” which cites poor w...
Siemens Healthineers: Good Return, Long-Term Potential Intact
Siemens Healthineers has seen a 7.5% increase in its stock price since the last article and has a solid upside potential. The company's recent results show strong revenue growth, margin improvements, ...
Siemens Healthineers Q1 sales beat expectations on strong Varian unit
German medical equipment maker Siemens Healthineers on Thursday posted first-quarter revenue above expectations and an operating result in line with consensus, driven by its U.S. cancer treatment unit...